These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 19803766)

  • 1. Empirical antimicrobial therapy for bloodstream infection due to methicillin-resistant Staphylococcus aureus: no better than a coin toss.
    Herzke CA; Chen LF; Anderson DJ; Choi Y; Sexton DJ; Kaye KS
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1057-61. PubMed ID: 19803766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk factors and antibiotic use in methicillin-resistant Staphylococcus aureus bacteremia in hospitalized patients at Hacettepe University Adult and Oncology Hospitals (2004-2011) and antimicrobial susceptibilities of the isolates: a nested case-control study].
    Atmaca O; Zarakolu P; Karahan C; Cakır B; Unal S
    Mikrobiyol Bul; 2014 Oct; 48(4):523-37. PubMed ID: 25492648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of bloodstream infections caused by methicillin-resistant Staphylococcus aureus at a tertiary care hospital in New York.
    Yasmin M; El Hage H; Obeid R; El Haddad H; Zaarour M; Khalil A
    Am J Infect Control; 2016 Jan; 44(1):41-6. PubMed ID: 26412481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy.
    Joo J; Yamaki J; Lou M; Hshieh S; Chu T; Shriner KA; Wong-Beringer A
    Clin Ther; 2013 Jul; 35(7):995-1004. PubMed ID: 23829982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between "classical" risk factors for infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and risk factors for nosocomial bloodstream infections caused by multiple clones of the staphylococcal cassette chromosome mec type IV MRSA strain.
    Vidal PM; Trindade PA; Garcia TO; Pacheco RL; Costa SF; Reinert C; Hiramatsu K; Mamizuka EM; Garcia CP; Levin AS
    Infect Control Hosp Epidemiol; 2009 Feb; 30(2):139-45. PubMed ID: 19146463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of Outcome in Hospitalized Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: Results From National Surveillance in Canada, 2008-2012.
    Simor AE; Pelude L; Golding G; Fernandes R; Bryce E; Frenette C; Gravel D; Katz K; McGeer A; Mulvey MR; Smith S; Weiss K;
    Infect Control Hosp Epidemiol; 2016 Apr; 37(4):390-7. PubMed ID: 26782274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy.
    Gasch O; Camoez M; Dominguez MA; Padilla B; Pintado V; Almirante B; Molina J; Lopez-Medrano F; Ruiz E; Martinez JA; Bereciartua E; Rodriguez-Lopez F; Fernandez-Mazarrasa C; Goenaga MA; Benito N; Rodriguez-Baño J; Espejo E; Pujol M;
    Clin Microbiol Infect; 2013 Nov; 19(11):1049-57. PubMed ID: 23331461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007.
    Burton DC; Edwards JR; Horan TC; Jernigan JA; Fridkin SK
    JAMA; 2009 Feb; 301(7):727-36. PubMed ID: 19224749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysis.
    Li Z; Zhuang H; Wang G; Wang H; Dong Y
    BMC Infect Dis; 2021 Jan; 21(1):74. PubMed ID: 33446122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysis.
    Yoon YK; Park DW; Sohn JW; Kim HY; Kim YS; Lee CS; Lee MS; Ryu SY; Jang HC; Choi YJ; Kang CI; Choi HJ; Lee SS; Kim SW; Kim SI; Kim ES; Kim JY; Yang KS; Peck KR; Kim MJ
    BMC Infect Dis; 2016 Jul; 16():331. PubMed ID: 27418274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of community-associated methicillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated bloodstream infections in Korea.
    Park SH; Park C; Yoo JH; Choi SM; Choi JH; Shin HH; Lee DG; Lee S; Kim J; Choi SE; Kwon YM; Shin WS
    Infect Control Hosp Epidemiol; 2009 Feb; 30(2):146-55. PubMed ID: 19128184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.
    Paul M; Kariv G; Goldberg E; Raskin M; Shaked H; Hazzan R; Samra Z; Paghis D; Bishara J; Leibovici L
    J Antimicrob Chemother; 2010 Dec; 65(12):2658-65. PubMed ID: 20947620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
    Coombs GW; Nimmo GR; Daly DA; Le TT; Pearson JC; Tan HL; Robinson JO; Collignon PJ; McLaws ML; Turnidge JD;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E309-19. PubMed ID: 25631593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?
    Ben-David D; Novikov I; Mermel LA
    Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.
    Moore CL; Osaki-Kiyan P; Haque NZ; Perri MB; Donabedian S; Zervos MJ
    Clin Infect Dis; 2012 Jan; 54(1):51-8. PubMed ID: 22109947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Molecular Characteristics of
    Hong SI; Lee YM; Park KH; Ryu BH; Hong KW; Kim S; Bae IG; Cho OH
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin.
    Yoon YK; Kim JY; Park DW; Sohn JW; Kim MJ
    J Antimicrob Chemother; 2010 May; 65(5):1015-8. PubMed ID: 20200036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.
    Casapao AM; Jacobs DM; Bowers DR; Beyda ND; Dilworth TJ;
    Pharmacotherapy; 2017 Nov; 37(11):1347-1356. PubMed ID: 28949410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating Central Catheter-Associated Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Beyond Vancomycin.
    Holt S; Thompson-Brazill KA; Sparks ER; Lipetzky J
    Crit Care Nurse; 2016 Aug; 36(4):46-57. PubMed ID: 27481801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.